Geneva Capital Management LLC Repligen Corp Transaction History

Geneva Capital Management LLC

  • $5.88 Billion
  • Q3 2024

A detailed history of Geneva Capital Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Geneva Capital Management LLC holds 138,677 shares of RGEN stock, worth $20 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
138,677
Previous 127,769 8.54%
Holding current value
$20 Million
Previous $16.1 Million 28.13%
% of portfolio
0.35%
Previous 0.3%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$119.79 - $167.35 $1.31 Million - $1.83 Million
10,908 Added 8.54%
138,677 $20.6 Million
Q2 2024

Aug 14, 2024
BUY
$120.0 - $182.95 $1.09 Million - $1.66 Million
9,051 Added 7.62%
127,769 $16.1 Million
Q1 2024

May 03, 2024
SELL
$170.78 - $208.42 $247,460 - $302,000
-1,449 Reduced 1.21%
118,718 $21.8 Million
Q4 2023

Feb 06, 2024
BUY
$114.17 - $185.35 $247,063 - $401,097
2,164 Added 1.83%
120,167 $21.6 Million
Q3 2023

Nov 13, 2023
SELL
$138.78 - $176.51 $777,584 - $988,985
-5,603 Reduced 4.53%
118,003 $18.8 Million
Q2 2023

Aug 01, 2023
SELL
$138.42 - $180.31 $906,235 - $1.18 Million
-6,547 Reduced 5.03%
123,606 $17.5 Million
Q1 2023

May 12, 2023
BUY
$154.26 - $198.1 $167,834 - $215,532
1,088 Added 0.84%
130,153 $21.9 Million
Q4 2022

Feb 07, 2023
SELL
$162.42 - $220.56 $2.01 Million - $2.72 Million
-12,348 Reduced 8.73%
129,065 $21.9 Million
Q3 2022

Nov 02, 2022
SELL
$160.42 - $256.21 $320,198 - $511,395
-1,996 Reduced 1.39%
141,413 $26.5 Million
Q2 2022

Aug 02, 2022
SELL
$140.68 - $188.02 $29,542 - $39,484
-210 Reduced 0.15%
143,409 $23.3 Million
Q1 2022

May 02, 2022
BUY
$161.19 - $257.96 $3 Million - $4.79 Million
18,582 Added 14.86%
143,619 $27 Million
Q4 2021

Feb 02, 2022
BUY
$247.59 - $304.47 $1.83 Million - $2.25 Million
7,404 Added 6.29%
125,037 $33.1 Million
Q3 2021

Nov 08, 2021
SELL
$194.77 - $324.21 $1.15 Million - $1.92 Million
-5,915 Reduced 4.79%
117,633 $34 Million
Q2 2021

Aug 11, 2021
SELL
$165.87 - $220.95 $730,491 - $973,063
-4,404 Reduced 3.44%
123,548 $24.7 Million
Q1 2021

May 03, 2021
SELL
$180.37 - $226.26 $5.4 Million - $6.78 Million
-29,949 Reduced 18.97%
127,952 $24.9 Million
Q4 2020

Feb 02, 2021
SELL
$148.08 - $206.57 $2.79 Million - $3.89 Million
-18,822 Reduced 10.65%
157,901 $30.3 Million
Q3 2020

Nov 12, 2020
BUY
$122.51 - $158.27 $1.79 Million - $2.31 Million
14,619 Added 9.02%
176,723 $26.1 Million
Q2 2020

Aug 13, 2020
BUY
$94.33 - $140.48 $7.41 Million - $11 Million
78,502 Added 93.9%
162,104 $20 Million
Q1 2020

May 15, 2020
BUY
$84.96 - $109.14 $7.1 Million - $9.12 Million
83,602 New
83,602 $8.07 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Geneva Capital Management LLC Portfolio

Follow Geneva Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email